|
1
|
Wang Z, Qin C, Zhang J, Han Z, Tao J, Cao
Q, Zhou W, Xu Z, Zhao C, Tan R and Gu M: MiR-122 promotes renal
cancer cell proliferation by targeting Sprouty 2. Tumour Biol.
39:10104283176911842017.PubMed/NCBI
|
|
2
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bharthuar A, Pandey H and Sood S:
Management of metastatic renal cell carcinoma-mini review. J Kidney
Cancer VHL. 2:75–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teixeira AL, Dias F, Gomes M, Fernandes M
and Medeiros R: Circulating biomarkers in renal cell carcinoma: The
link between microRNAs and extracellular vesicles, where are we
now? J Kidney Cancer VHL. 1:84–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aguiari G: MicroRNAs in clear cell renal
cell carcinoma: Biological functions and applications. J Kidney
Cancer VHL. 2:140–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ling H, Girnita L, Buda O and Calin GA:
Non-coding RNAs: The cancer genome dark matter that matters! Clin
Chem Lab Med. 55:1–714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang T, Hu XY, Li YH, Tian BQ, Li ZW and
Fu Q: MicroRNA-21 regulates the proliferation, differentiation, and
apoptosis of human renal cell carcinoma cells by the mTOR-STAT3
signaling pathway. Oncol Res. 24:371–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao H, Xiao W, Cao J, Li H, Guan W, Guo
X, Chen K, Zheng T, Ye Z, Wang J and Xu H: miR-206 functions as a
novel cell cycle regulator and tumor suppressor in clear-cell renal
cell carcinoma. Cancer Lett. 374:107–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu F, Chen N, Xiao R, Wang W and Pan Z:
miR-144-3p serves as a tumor suppressor for renal cell carcinoma
and inhibits its invasion and metastasis by targeting MAP3K8.
Biochem Biophys Res Commun. 480:87–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeong JY, Kang H, Kim TH, Kim G, Heo JH,
Kwon AY, Kim S, Jung SG and An HJ: MicroRNA-136 inhibits cancer
stem cell activity and enhances the anti-tumor effect of paclitaxel
against chemoresistant ovarian cancer cells by targeting Notch3.
Cancer Lett. 386:168–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan M, Li X, Tong D, Han C, Zhao R, He Y
and Jin X: miR-136 suppresses tumor invasion and metastasis by
targeting RASAL2 in triple-negative breast cancer. Oncol Rep.
36:65–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen S, Yue H, Li Y, Qin J, Li K, Liu Y
and Wang J: Upregulation of miR-136 in human non-small cell lung
cancer cells promotes Erk1/2 activation by targeting PPP2R2A.
Tumour Biol. 35:631–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kotlabova K, Doucha J and Hromadnikova I:
Placental-specific microRNA in maternal circulation-identification
of appropriate pregnancy-associated microRNAs with diagnostic
potential. J Reprod Immunol. 89:185–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tusong H, Maolakuerban N, Guan J, Rexiati
M, Wang WG, Azhati B, Nuerrula Y and Wang YJ: Functional analysis
of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Cancer Biomarker. 18:79–85. 2017. View Article : Google Scholar
|
|
20
|
Yang Y, Liu L, Cai J, Wu J, Guan H, Zhu X,
Yuan J, Chen S and Li M: Targeting Smad2 and Smad3 by miR-136
suppresses metastasis-associated traits of lung adenocarcinoma
cells. Oncol Res. 21:345–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mosakhani N, Pazzaglia L, Benassi MS,
Borze I, Quattrini I, Picci P and Knuutila S: MicroRNA expression
profiles in metastatic and non-metastatic giant cell tumor of bone.
Histol Histopathol. 28:671–678. 2013.PubMed/NCBI
|
|
22
|
Yang Y, Wu J, Guan H, Cai J, Fang L, Li J
and Li M: MiR-136 promotes apoptosis of glioma cells by targeting
AEG-1 and Bcl-2. FEBS Lett. 586:3608–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jeansonne D, Pacifici M, Lassak A, Reiss
K, Russo G, Zabaleta J and Peruzzi F: Differential effects of
MicroRNAs on glioblastoma growth and migration. Genes (Basel).
4:46–64. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao H, Liu S, Wang G, Wu X, Ding Y, Guo
G, Jiang J and Cui S: Expression of miR-136 is associated with the
primary cisplatin resistance of human epithelial ovarian cancer.
Oncol Rep. 33:591–598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao H, Song X, Kang T, Yan B, Feng L, Gao
L, Ai L, Liu X, Yu J and Li H: Long noncoding RNA CRNDE functions
as a competing endogenous RNA to promote metastasis and oxaliplatin
resistance by sponging miR-136 in colorectal cancer. Onco Targets
Ther. 10:205–216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hao JF, Ren KM, Bai JX, Wang SN, Shao B,
Cao N and Li X: Identification of potential biomarkers for clear
cell renal cell carcinoma based on microRNA-mRNA pathway
relationships. J Cancer Res Ther. 10 Suppl:C167–C177. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu H, Liu Q, Cai T, Chen YD, Liao F and
Wang ZF: MiR-136 modulates glioma cell sensitivity to temozolomide
by targeting astrocyte elevated gene-1. Diagn Pathol. 9:1732014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Yang Y, Chen B, Lu P, Zhan L, Yu
Q, Cao K and Li Q: MiR-136 targets E2F1 to reverse cisplatin
chemosensitivity in glioma cells. J Neurooncol. 120:43–53. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao J, Wang W, Huang Y, Wu J, Chen M, Cui
P, Zhang W and Zhang Y: HBx elevates oncoprotein AEG-1 expression
to promote cell migration by downregulating miR-375 and miR-136 in
malignant hepatocytes. DNA Cell Biol. 33:715–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ji L, Zhang L, Li Y, Guo L, Cao N, Bai Z,
Song Y, Xu Z, Zhang J, Liu C and Ma X: MiR-136 contributes to
pre-eclampsia through its effects on apoptosis and angiogenesis of
mesenchymal stem cells. Placenta. 50:102–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang D, Wang J, Wang Z, Zhang T, Shi P,
Wang X, Zhao F, Liu X, Lin X and Pang X: miR-136 modulates
TGF-beta1-induced proliferation arrest by targeting PPP2R2A in
keratinocytes. Biomed Res Int. 2015:4535182015.PubMed/NCBI
|
|
32
|
Zhang CF, Kang K, Li XM and Xie BD:
MicroRNA-136 promotes vascular muscle cell proliferation through
the ERK1/2 pathway by targeting PPP2R2A in atherosclerosis. Curr
Vasc Pharmacol. 13:405–412. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
